These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 2905248)
1. Pharmacokinetics of roxatidine in healthy volunteers. Collins JD; Pidgen AW Drugs; 1988; 35 Suppl 3():41-7. PubMed ID: 2905248 [TBL] [Abstract][Full Text] [Related]
2. The pharmacodynamics and pharmacokinetics of multiple doses of the new H2-receptor antagonist, roxatidine acetate, in healthy men. Lassman HB; Ho I; Puri SK; Sabo R; Scheffler MR Drugs; 1988; 35 Suppl 3():53-64. PubMed ID: 2905250 [TBL] [Abstract][Full Text] [Related]
4. [Plasma pharmacokinetics of roxatidine in the healthy man: correlation with gastric antisecretory effect]. Chen WW; Kolsky H; Lewin MJ; Bonfils S Gastroenterol Clin Biol; 1990; 14(4):342-6. PubMed ID: 1972124 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of the H(2) blocker roxatidine acetate hydrochloride in pediatric patients, in comparison with healthy adult volunteers. Nakamura H; Kawashima H; Azuma R; Sato I; Nagao K; Miyazawa K Drug Metab Pharmacokinet; 2012; 27(4):422-9. PubMed ID: 22293541 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of roxatidine acetate in patients with chronic liver disease. Tsutsumi M; Ueshima Y; Takase S J Gastroenterol Hepatol; 2001 Aug; 16(8):910-5. PubMed ID: 11555106 [TBL] [Abstract][Full Text] [Related]
7. Effects of roxatidine acetate on 24-hour gastric acidity. Early evening versus bedtime administration in healthy subjects. Hemery P; Congard P; Galmiche JP; Bonfils S Drugs; 1988; 35 Suppl 3():76-81. PubMed ID: 2905253 [TBL] [Abstract][Full Text] [Related]
8. Determination of roxatidine in human plasma, urine and milk by capillary gas chromatography using nitrogen-selective detection. Burrows JL; Jolley KW; Sullivan DJ J Chromatogr; 1988 Nov; 432():199-208. PubMed ID: 2906063 [TBL] [Abstract][Full Text] [Related]
9. Roxatidine acetate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic potential in peptic ulcer disease and related disorders. Murdoch D; McTavish D Drugs; 1991 Aug; 42(2):240-60. PubMed ID: 1717223 [TBL] [Abstract][Full Text] [Related]
10. A pharmacokinetic study of roxatidine acetate in chronic renal failure. Lameire N; Rosenkranz B; Maass L; Brockmeier D Drugs; 1988; 35 Suppl 3():48-52. PubMed ID: 2905249 [TBL] [Abstract][Full Text] [Related]
11. Interaction of roxatidine acetate with antacids, food and other drugs. Labs RA Drugs; 1988; 35 Suppl 3():82-9. PubMed ID: 2905254 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics of roxatidine in patients with renal insufficiency. Gladziwa U; Wagner S; Sieberth HG; Klotz U Br J Clin Pharmacol; 1995 Feb; 39(2):161-7. PubMed ID: 7742154 [TBL] [Abstract][Full Text] [Related]
13. Single-dose and multiple-dose pharmacokinetics of etintidine in healthy volunteers. Huang SM; Marriott TB; Weintraub HS; Arnold JD; Boccagno J; Abels R; Harris W Eur J Clin Pharmacol; 1988; 34(1):101-4. PubMed ID: 2896125 [TBL] [Abstract][Full Text] [Related]
14. The effect of roxatidine acetate and cimetidine on hepatic drug clearance assessed by simultaneous administration of three model substrates. Tanaka E; Nakamura K Br J Clin Pharmacol; 1989 Aug; 28(2):171-4. PubMed ID: 2570603 [TBL] [Abstract][Full Text] [Related]
15. A review of the animal pharmacology of roxatidine acetate. Scholtholt J; Bickel M; Herling AW Drugs; 1988; 35 Suppl 3():30-40. PubMed ID: 2905247 [TBL] [Abstract][Full Text] [Related]
16. Lack of effect of multiple dose sucralfate on the pharmacokinetics of of roxatidine acetate. Seibert-Grafe M; Pidgen A Eur J Clin Pharmacol; 1991; 40(6):637-8. PubMed ID: 1679394 [No Abstract] [Full Text] [Related]
17. Pharmacokinetics of histamine (H2)-receptor antagonists, including roxatidine, in chronic renal failure. Lameire N; Rosenkranz B; Brockmeier D Scand J Gastroenterol Suppl; 1988; 146():100-10. PubMed ID: 2906455 [TBL] [Abstract][Full Text] [Related]
18. Penetration of roxatidine into the cerebrospinal fluid. Tryba M; Kurz-Muller K Scand J Gastroenterol Suppl; 1988; 146():153-8. PubMed ID: 2906459 [TBL] [Abstract][Full Text] [Related]
19. The effects of roxatidine acetate on 24-hour intragastric acidity. Investigations in healthy volunteers and comparison with ranitidine and placebo. Merki HS; Witzel L; Kaufmann D; Kempf M; Neumann J; Scheurle E; Röhmel J; Walt RP Drugs; 1988; 35 Suppl 3():69-75. PubMed ID: 2905252 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of the H1-receptor antagonist ebastine and its active metabolite carebastine in healthy subjects. Yamaguchi T; Hashizume T; Matsuda M; Sakashita M; Fujii T; Sekine Y; Nakashima M; Uematsu T Arzneimittelforschung; 1994 Jan; 44(1):59-64. PubMed ID: 7907873 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]